Targeting CD44-STAT3 Signaling by Gemini Vitamin D Analog Leads to Inhibition of Invasion in Basal-Like Breast Cancer

Documenti analoghi

• Targeting CD44-STAT3 signaling by Gemini vitamin D analog leads to inhibition of invasion in basal-like breast cancer.
  di: Jae Young So, et al.
  Pubblicazione: (2013-01-01)
• HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(−/low) tumor-initiating subpopulation in basal-like breast cancer
  di: So, Jae Young, et al.
  Pubblicazione: (2014)
• A Novel Gemini Vitamin D Analog Represses the Expression of a Stem Cell Marker CD44 in Breast Cancer
  di: So, Jae Young, et al.
  Pubblicazione: (2011)
• Gemini Vitamin D Analog Suppresses ErbB2-Positive Mammary Tumor Growth via Inhibition of ErbB2/AKT/ERK Signaling
  di: Lee, Hong Jin, et al.
  Pubblicazione: (2010)
• Inhibition of the Transition of Ductal Carcinoma In Situ to Invasive Ductal Carcinoma by a Gemini Vitamin D Analog
  di: Wahler, Joseph, et al.
  Pubblicazione: (2014)